{"id":65195,"date":"2025-07-14T15:29:12","date_gmt":"2025-07-14T15:29:12","guid":{"rendered":"https:\/\/www.europesays.com\/us\/65195\/"},"modified":"2025-07-14T15:29:12","modified_gmt":"2025-07-14T15:29:12","slug":"ozempic-set-to-become-more-affordable-accessible-in-canada-raising-concerns-of-drug-abuse-ctv-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/65195\/","title":{"rendered":"Ozempic set to become more affordable, accessible in Canada \u2014 raising concerns of drug abuse – CTV News"},"content":{"rendered":"
    \n
  1. Ozempic set to become more affordable, accessible in Canada \u2014 raising concerns of drug abuse<\/a>  CTV News<\/li>\n
  2. Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses<\/a>  CNBC<\/li>\n
  3. Citi reiterates Sell rating on Hims and Hers stock as company expands to Canada<\/a>  Investing.com<\/li>\n
  4. Hims & Hers’ Canadian Gamble: Can Generic Semaglutide Unlock a $4 Billion Market?<\/a>  AInvest<\/li>\n
  5. Hims & Hers expands into Canada as generic semaglutide drug market opens up<\/a>  Fierce Healthcare<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Ozempic set to become more affordable, accessible in Canada \u2014 raising concerns of drug abuse  CTV News Hims &…\n","protected":false},"author":3,"featured_media":65196,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[4717,210,1060,67,132,68],"class_list":{"0":"post-65195","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-apple-news","9":"tag-health","10":"tag-medication","11":"tag-united-states","12":"tag-unitedstates","13":"tag-us"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/65195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=65195"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/65195\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/65196"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=65195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=65195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=65195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}